MYC and head and neck squamous cell carcinoma: We also showed that an inhibitor of the related kinase DLK, GNE-3511, effectively and specifically impaired viability and colony formation of 3q amplicon-positive HNSCC cells and significantly decreased expression of c-MYC, which could be rescued by expression of a drug-resistant mutant form of LZK.